16 analysts have expressed a variety of opinions on Comerica CMA over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 8 | 3 | 0 |
| Last 30D | 0 | 1 | 2 | 2 | 0 |
| 1M Ago | 1 | 1 | 3 | 1 | 0 |
| 2M Ago | 0 | 2 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Comerica, presenting an average target of $63.62, a high estimate of $75.00, and a low estimate of $51.00. Surpassing the previous average price target of $56.12, the current average has increased by 13.36%.
Investigating Analyst Ratings: An Elaborate Study
The standing of Comerica among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Brandon King | Truist Securities | Raises | Hold | $70.00 | $66.00 |
| Mike Mayo | Wells Fargo | Raises | Underweight | $51.00 | $43.00 |
| Terry McEvoy | Stephens & Co. | Raises | Overweight | $70.00 | $64.00 |
| Anthony Elian | JP Morgan | Raises | Neutral | $70.00 | $65.00 |
| Jason Goldberg | Barclays | Raises | Underweight | $66.00 | $56.00 |
| Steven Alexopoulos | JP Morgan | Raises | Neutral | $65.00 | $57.00 |
| Ryan Nash | Goldman Sachs | Raises | Buy | $63.00 | $55.00 |
| Ebrahim Poonawala | B of A Securities | Lowers | Underperform | $52.00 | $55.00 |
| John Pancari | Evercore ISI Group | Raises | In-Line | $64.00 | $58.00 |
| Manan Gosalia | Morgan Stanley | Raises | Equal-Weight | $63.00 | $61.00 |
| David Chiaverini | Wedbush | Raises | Outperform | $75.00 | $52.00 |
| Brandon King | Truist Securities | Raises | Hold | $66.00 | $53.00 |
| Terry McEvoy | Stephens & Co. | Maintains | Overweight | $58.00 | $58.00 |
| Peter Winter | DA Davidson | Maintains | Neutral | $55.00 | $55.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Raises | Outperform | $69.00 | $50.00 |
| Manan Gosalia | Morgan Stanley | Raises | Equal-Weight | $61.00 | $50.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Comerica. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Comerica's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Comerica's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Comerica analyst ratings.
Get to Know Comerica Better
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
Financial Milestones: Comerica's Journey
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Comerica's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -10.82%. This indicates a decrease in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 24.27%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Comerica's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.5% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Comerica's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.25%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Comerica's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.45.
The Basics of Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
